Navigation Links
Presentation of HeartWare Clinical Results
Date:4/15/2008

Survival Rate of 91% Among First 23 Patients

FRAMINGHAM, Mass., SYDNEY, Australia, April 15 /PRNewswire-FirstCall/ -- HeartWare Limited (ASX: HTW), a developer of miniaturized implantable heart pumps to treat advanced heart failure, today announced initial results from an international clinical trial of the HeartWare(R) Left Ventricular Assist System. The results were presented by Dr. Georg Wieselthaler, cardiothoracic surgeon at Vienna General Hospital, at the annual meeting of the International Society for Heart and Lung Transplantation held in Boston.

The data presented by Dr Wieselthaler show a six-month survival rate of 91 percent among the first 23 patients implanted with the HeartWare device. Of the 23 patients, 21 patients met the primary endpoint of the trial, defined as survival to 180 days or transplantation. These included 19 patients who were supported by the HeartWare system at 180 days and two patients who received transplants, after 157 days and 176 days respectively.

Dr. Wieselthaler noted that one of the key features of the pump is its small size, which allows it to be implanted in the chest, thereby avoiding the abdominal surgery generally required to implant competing devices.

HeartWare CEO Mr. Douglas Godshall said the early clinical success of the HeartWare pump is a key outcome for the Company as it accelerates its efforts to make the device available to patients in the United States and around the world.

"These results are very promising," Mr. Godshall said. "Our early data appears to validate the benefits we believe to be inherent in the design of our device -- namely its small size, pericardial placement and wearless mechanism. These results give us great confidence as we move towards the start of our U.S. clinical trial and towards commercial release of the product in Europe."

To date a total of 32 patients have been enrolled in HeartWare's international clinical trial. The avera
'/>"/>

SOURCE HeartWare Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
4. Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO)
5. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
6. Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference
7. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
8. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
9. IDM Pharma Announces Upcoming Clinical Data Presentations
10. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
11. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Nonin Medical, a global leader in noninvasive medical monitoring, ... Steve Bucholz will retire May 1. Company founder ... Chief Executive Officer. In addition, Mr. Isaacson will continue ... transition to David Noel , Chief Financial Officer. ... to Nonin Medical,s growth," Mr. Isaacson said. "Under Steve,s ...
(Date:4/17/2015)... R.I , April 17, 2015 CVS ... a conference call on Friday, May 1, 2015, at ... its first quarter financial results. An audio ... through the Investor Relations portion of the CVS Health ... visit http://investors.cvshealth.com . This webcast will be archived ...
(Date:4/17/2015)... ASSESS shows   plasma circulating tumour DNA (ctDNA) ... tumour biopsy   IGNITE supports value of ... AstraZeneca today presented results from two key studies ... for epidermal growth factor receptor (EGFR) mutation status in newly ... clinical practice. [ 1 ] , ...
Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... AUG. 2 Two major studies,published today in The ... pregnant women at risk for preterm delivery who can ... today. In one large multi-center trial led by ... whom had no prior history of preterm birth) who,received ...
... Population of Glioblastoma Patients Expected to Support ... Promising New Approach -, TUSTIN, Calif., Aug. 2 ... stage biopharmaceutical,company developing targeted monoclonal antibodies for the treatment ... the first,patient has been administered Cotara(R) in a new ...
Cached Medicine Technology:Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 3Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 4
(Date:4/19/2015)... Philadelphia, Pennslyvania (PRWEB) April 19, 2015 ... and proved tolerable in a small group of healthy ... (UPCI), partner with UPMC CancerCenter , announced ... (AACR) Annual Meeting in Philadelphia. , The ... clinical trial, which will recruit participants at high risk ...
(Date:4/19/2015)... 2015 New court documents issued by ... that Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) continue to mount ... District of South Carolina. According to the April 15th ... in the proceeding on behalf of individuals who allegedly ... the cholesterol-lowering statin. This represents an increase of 110 ...
(Date:4/19/2015)... April 19, 2015 Family and friends of ... Brains in Memory of Brad Baddeley event to honor ... Foundation. , Bowling for Brains is cheduled to take place ... Dudley Street in Lincoln, Nebraska. Participants may arrive at 12:30pm ... 3:00pm. , The cost is only $4 per game and ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancequotesinfo.com has ... insurance can cover physical injuries caused by a ... excellent financial coverage for a vehicle. A policy can ... by an accident. Drivers should always carry appropriate coverage ... insurance policy can be bought with several important riders ...
(Date:4/18/2015)... 2015 Review of Ophthalmology magazine and ... for Success’ program for cataract surgeons attending the American ... Diego, where eye surgeon Jeffrey L. Martin, MD will ... Dr. Martin is the Managing Partner of North Shore ... Dr. Martin to lead this year’s discussion on the ...
Breaking Medicine News(10 mins):Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... Thursday asked the government, the railway ministry and the Indian ... petition accusing them of supplying unhygienic food to rail passengers.// ... Khetrapal issued notice to the respondents to file their replies ... entrusted with the task of supplying food to passengers on ...
... Society Wolfson Research Professor and inventor of DNA Fingerprinting ... which will be awarded to him later this year. ... Heineken Prize for Biochemistry and Biophysics 2006 by the ... of the discovery of the revolutionary technique. ...
... shake-up of the out of hours health care system in England ... ,The public accounts committee claimed that the new health ... met many key targets. ,In 2004 most GPs had ... which PCTs took over in 90% of cases. ,The ...
... launched by the Cancer Research UK, and its ... take up// drug candidates that pharmaceuticals companies have ... their preclinical studies. By this they plan to ... been shelved by pharmaceutical and biotechnology companies. ...
... and Aberdeen University in Scotland found that women with ... have twins// following in vitro fertilization. They found that ... multiple births after fertility treatment. ,However, the ... protects against birth defects such as spina bifida, does ...
... Embryology Authority show that recently there is a surge ... technology// (ART) in the UK. It is astonishing to ... 34. There is increase in women choosing to delay ... and scientists say that there are long-term risks associated ...
Cached Medicine News:Health News:Inventor of DNA fingerprinting Wins Accolades 2Health News:Cancer Research UK Offers New Hope To Cancer Patients 2Health News:High Levels Of Folic Acid May Increase The Chances Of Twins After IVF 2
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
Medicine Products: